Symphony Asset Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-1,466
Closed -$224K 71
2019
Q4
$224K Sell
1,466
-51
-3% -$7.06K 0.05% 151
2019
Q3
$201K Sell
1,517
-51
-3% -$6.84K 0.04% 168
2019
Q2
$222K Sell
1,568
-28
-2% -$3.8K 0.05% 151
2019
Q1
$232K Sell
1,596
-670
-30% -$88K 0.06% 149
2018
Q4
$256K Sell
2,266
-70
-3% -$8.76K 0.08% 132
2018
Q3
$314K Sell
2,336
-155
-6% -$19.1K 0.08% 139
2018
Q2
$278K Sell
2,491
-3,815
-60% -$412K 0.06% 195
2018
Q1
$673K Sell
6,306
-57
-0.9% -$6.14K 0.09% 207
2017
Q4
$697K Sell
6,363
-186
-3% -$20.2K 0.07% 220
2017
Q3
$708K Sell
6,549
-445
-6% -$45.7K 0.08% 221
2017
Q2
$708K Buy
+6,994
New +$644K 0.08% 222

Other funds holding CRL